eGFR cystatinC /eGFR creatinine ratio < 0.6 in patients with SARS-CoV-2 pneumonia: a prospective cohort study.
Lauris AvotinsJuta KroicaAivars PetersonsDace ZentinaZaiga KravaleAnna SauliteKarlis RacenisPublished in: BMC nephrology (2023)
We prove that reduced ratio is common in hospitalized patients with SARS-CoV-2 pneumonia and is associated with increased mortality during hospitalization. Factors that influence this ratio are complex and, in addition to the possible shrinkage of pores, other conditions such as thickening of glomerular basal membrane, comorbidities, prerenal kidney failure and others may play an important role and should be addressed when diagnosing SPS. We highlight the need for additional diagnostic criteria for SPS and larger studies to better understand its implications in acute COVID-19 settings.
Keyphrases
- sars cov
- small cell lung cancer
- respiratory syndrome coronavirus
- respiratory failure
- epidermal growth factor receptor
- tyrosine kinase
- liver failure
- coronavirus disease
- cardiovascular events
- risk factors
- intensive care unit
- metabolic syndrome
- community acquired pneumonia
- coronary artery disease
- high glucose
- hepatitis b virus